Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01565083
Brief Title: A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer (VELVET)

First Submitted : March 26, 2012
First Submitted that Met QC Criteria : March 27, 2012
First Posted : March 28, 2012 (Estimate)

Results First Submitted : September 30, 2016
Results First Submitted that Met QC Criteria : September 30, 2016
Results First Posted : November 22, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 30, 2016
Last Update Posted : November 22, 2016 (Estimate)